https://www.selleckchem.com/pr....oducts/Trichostatin-
This adds a third allelic variant to the pathophysiology of NFKB2-mediated immunodeficiency disorders.The management of acute massive pulmonary embolism (PE) patients who did not respond to systemic thrombolysis (ST) has not been well established. The present study aimed to investigate the safety and effectiveness of catheter-based therapies (CDT) in this condition. We conducted a retrospective study of PE patients after unsuccessful ST (UST) between January 2012 and January 2018. Massive PE was identified in 408 patients and tre
Beğen
Yorum Yap
Paylaş
